Sanford Consortium for Regenerative Medicine and Takeda Pharmaceutical Company Innovation Alliance
Overview
The Sanford Consortium for Regenerative Medicine and Takeda Pharmaceutical Company have established a five-year, $10-million Innovation Alliance to foster scientific collaborations and advance each organization’s research missions. Through this partnership, basic and translational stem-cell research projects entailing novel and integrative concepts and methods will be identified and supported.
The Innovation Alliance completed two funding cycles (2016 and 2018) and supported sixteen collaborative projects comprising Gastroenterology, Neuroscience, Oncology and Regenerative Medicine focus areas.
It is possible that announcement of the next funding cycle will be posted here in 2021.